+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Immunity Booster Supplement Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5181420
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Immunity Booster Supplement Market is undergoing rapid transformation as evolving consumer expectations and scientific advancements drive significant changes in product development, distribution, and sourcing strategy. Senior decision-makers must navigate a complex landscape shaped by innovation in formats, ingredient credibility, and regional regulations.

Market Snapshot

The global immunity booster supplement market grew from USD 15.22 billion in 2025 to USD 16.47 billion in 2026, with expected growth at a CAGR of 10.06% to reach USD 29.78 billion by 2032. This sustained expansion reflects heightened consumer focus on preventive wellness, ongoing product innovation, and cross-channel accessibility that continues to redefine the competitive arena for leading and emerging brands alike.

Scope & Segmentation

  • Format Types: Effervescent, gummy, liquid, powder, softgel, tablet, and capsule supplements cater to distinct user preferences and compliance behaviors across demographic groups.
  • Ingredient Types: Herbal extracts, multivitamins, probiotics, vitamin C, and zinc, each verified for efficacy and safety, serve diverse health narratives and claims.
  • Distribution Channels: E-commerce platforms, direct sales, pharmacies, retail outlets, and specialty stores, each presenting unique opportunities and channel-specific demands.
  • Demographic Segments: Formulations and messaging are tailored for age, gender, and lifestyle, such as bone health for women or recovery-focus for men.
  • Regional Insights: Americas emphasize transparency and clinical evidence; Europe, Middle East & Africa focus on regulatory navigation and natural solutions; Asia-Pacific balances tradition, rapid digital growth, and regional sourcing partnerships.
  • Regulatory & Compliance Standards: Product development must align with evolving global and local documentation, traceability, and labeling requirements.

Key Takeaways

  • Evidence-led product design is central, with brands leveraging clinical studies, biomarker validation, and standardized extracts to substantiate health benefits and build consumer trust.
  • Personalization is moving from aspirational to actionable, as manufacturers develop differentiated formulations targeting specific demographics, preferences, and health priorities.
  • Format innovation supports user experience, with each option—effervescent, gummies, liquids, softgels, powders, tablets, or capsules—tailored to consumption habits and driving adherence or flexibility.
  • Channel convergence allows integrated strategies; e-commerce growth supports personalized offerings and subscription models while strengthening direct consumer engagement, complemented by pharmacy and retail relationships for clinical credibility.
  • Ingredient transparency and supply chain traceability are fast becoming strategic imperatives, with investments in digital tracking and supplier diversification to maintain agility and regulatory compliance.
  • Innovative approaches to regional market entry, including contract manufacturing and local partnerships, optimize responsiveness amid diverse consumer and regulatory landscapes.

Tariff Impact

Tariff adjustments introduced in 2025 have direct implications for sourcing strategies and supply-chain resilience across immunity supplement manufacturing. Increased input costs have prompted procurement teams to reevaluate supplier agreements, diversify sources, and invest in traceability and compliance frameworks. These pressures reinforce the importance of agile sourcing, transparency in documentation, and operational cost management as brands respond with nearshoring and streamlined ingredient qualification processes. The market has seen greater scrutiny in customs documentation and more rigorous quality audits to assist both compliance and margin preservation efforts.

Methodology & Data Sources

This report uses an integrated research methodology combining primary interviews with industry executives, secondary review of scientific publications, regulatory guidance, and analytical techniques such as trend triangulation and supply-chain mapping. Validation workshops with independent subject-matter experts ensure actionable and reliable recommendations for decision-makers.

Why This Report Matters

  • Delivers granular segmentation and channel insights for informed strategy, marketing, and portfolio allocation decisions in the immunity booster supplement market.
  • Equips leaders to mitigate external shocks, such as tariff volatility or regulatory change, by providing evidence-driven actions for sourcing, product development, and go-to-market execution.
  • Supports rapid adaptation to consumer health priorities and regional market realities, enabling operational resilience and competitive differentiation.

Conclusion

Execution based on scientific rigor, agile supply chains, and region-specific channel strategies will drive sustainable advantage. With evidence, transparency, and tailored innovation, organizations are positioned to convert market complexity into ongoing commercial success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immunity Booster Supplement Market, by Ingredient Type
8.1. Herbal Extracts
8.2. Multivitamins
8.3. Probiotics
8.4. Vitamin C
8.5. Zinc
9. Immunity Booster Supplement Market, by Form
9.1. Effervescent
9.2. Gummy
9.3. Liquid
9.4. Powder
9.5. Softgel
10. Immunity Booster Supplement Market, by Product Type
10.1. Herbal
10.2. Natural
10.3. Synthetic
11. Immunity Booster Supplement Market, by Usage Frequency
11.1. Short-Term Therapeutic Use
11.2. Long-Term Maintenance Use
12. Immunity Booster Supplement Market, by Distribution Channel
12.1. Online
12.2. Offline
13. Immunity Booster Supplement Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Immunity Booster Supplement Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Immunity Booster Supplement Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Immunity Booster Supplement Market
17. China Immunity Booster Supplement Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Amway Corp.
18.6. Bayer AG
18.7. Glanbia plc
18.8. GNC Holdings, LLC
18.9. Herbalife Nutrition Ltd.
18.10. Nature's Sunshine Products, Inc.
18.11. Nestlé S.A.
18.12. NOW Health Group, Inc.
18.13. Reckitt Benckiser Group plc
18.14. Sanofi S.A.
18.15. Swisse Wellness Pty Ltd
18.16. The Nature's Bounty Co.
List of Figures
FIGURE 1. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY MULTIVITAMINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY MULTIVITAMINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY MULTIVITAMINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY VITAMIN C, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ZINC, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ZINC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ZINC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY EFFERVESCENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY EFFERVESCENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY EFFERVESCENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GUMMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GUMMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GUMMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SOFTGEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SOFTGEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SOFTGEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY HERBAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SHORT-TERM THERAPEUTIC USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SHORT-TERM THERAPEUTIC USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SHORT-TERM THERAPEUTIC USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LONG-TERM MAINTENANCE USE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LONG-TERM MAINTENANCE USE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY LONG-TERM MAINTENANCE USE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 86. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 91. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 97. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 98. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 100. AFRICA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 110. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 111. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 113. ASEAN IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 116. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 117. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 119. GCC IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 128. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 129. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 131. BRICS IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 134. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 135. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 137. G7 IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 140. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 141. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 143. NATO IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 147. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 152. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY INGREDIENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 154. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY USAGE FREQUENCY, 2018-2032 (USD MILLION)
TABLE 156. CHINA IMMUNITY BOOSTER SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Immunity Booster Supplement market report include:
  • Amway Corp.
  • Bayer AG
  • Glanbia plc
  • GNC Holdings, LLC
  • Herbalife Nutrition Ltd.
  • Nature's Sunshine Products, Inc.
  • Nestlé S.A.
  • NOW Health Group, Inc.
  • Reckitt Benckiser Group plc
  • Sanofi S.A.
  • Swisse Wellness Pty Ltd
  • The Nature's Bounty Co.

Table Information